Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Epistaxis
ADR ID BADD_A01528
ADR Hierarchy
22      Respiratory, thoracic and mediastinal disorders
22.04      Upper respiratory tract disorders (excl infections)
22.04.03      Nasal disorders NEC
22.04.03.001      Epistaxis
24      Vascular disorders
24.07      Vascular haemorrhagic disorders
24.07.01      Haemorrhages NEC
24.07.01.005      Epistaxis
Description A disorder characterized by bleeding from the nose. [CTCAE] Bleeding from the nose. [MeSH]
MedDRA Code 10015090
MeSH ID D004844
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Bleeding nose | Epistaxis | Haemorrhage nasal | Hemorrhage nasal | Nasal bleeding | Nasal mucus blood tinged | Nose bleed | Nose bleeds | Nosebleed | Chronic epistaxis | Blood clot in nose | Nasal Bleeding | Bleeding, Nasal | Bleedings, Nasal | Nasal Bleedings | Nose Bleed | Nose Bleeds | Nosebleeds
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01310Lomefloxacin hydrochloride--
BADD_D01317Loratadine0.000126%
BADD_D01318Lorazepam--
BADD_D01322Losartan0.000081%
BADD_D01323Losartan potassium--
BADD_D01336Macitentan0.009194%
BADD_D01366Medroxyprogesterone acetate--
BADD_D01376Melphalan0.000112%
BADD_D01378Memantine--
BADD_D01381Mepact--
BADD_D01393Meropenem--
BADD_D01394Merrem i.v.--
BADD_D01397Mesalamine--
BADD_D01418Methotrexate--
BADD_D01419Methotrexate sodium--
BADD_D01431Methylphenidate--
BADD_D01441Metipranolol--
BADD_D01444Metolazone--
BADD_D01455Micafungin--
BADD_D01456Micafungin sodium--
BADD_D01465Miglustat0.006469%
BADD_D01469Miltefosine--
BADD_D01476Mirtazapine--
BADD_D01477Misoprostol--
BADD_D01484Modafinil--
BADD_D01490Mometasone0.001875%
BADD_D01491Mometasone furoate0.006043%
BADD_D01492Mometasone furoate monohydrate--
BADD_D01496Montelukast0.000215%
BADD_D01497Montelukast sodium--
The 11th Page    First    Pre   11 12 13 14 15    Next   Last    Total 20 Pages